First published online 21 January 2009
doi: 10.1242/dev.024703
Development 136, 749-760 (2009)
Published by The Company of Biologists 2009
Identification of direct T-box target genes in the developing zebrafish mesoderm
Aaron T. Garnett1,
Tina M. Han1,
Michael J. Gilchrist2,
James C. Smith2,3,
Michael B. Eisen1,4,5,
Fiona C. Wardle6 and
Sharon L. Amacher1,*
1 Department of Molecular and Cell Biology and Center for Integrative Genomics,
University of California, Berkeley CA 94720, USA.
2 Wellcome Trust/Cancer Research UK Gurdon Institute, Tennis Court Road,
Cambridge, CB2 1QN, UK.
3 Department of Zoology, Tennis Court Road, Cambridge CB2 1QN, UK.
4 Genomics Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720,
USA.
5 California Institute for Quantitative Biosciences, Berkeley, CA 94158,
USA.
6 Department of Physiology, Development and Neuroscience, Anatomy Building,
Downing Street, Cambridge CB2 3DY, UK.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 1. Microarray analysis identifies candidate spt and ntl
target genes. (A) Gene expression levels in MO-injected embryos
relative to wild-type embryos at 75% epiboly. Downregulation is shown in
shades of yellow (2 to >8-fold) and upregulation (2 to 3-fold) is shown in
light purple. Only genes with a two-fold or greater decrease in expression
level are shown. (B) spadetail (spt) and no tail
(ntl) gene expression profiles between 3 and 48 hpf are shown (top) with
the expression profiles of putative targets below. These gene expression
profiles were retrieved from another dataset
(Mathavan et al., 2005 ). The
expression level for each gene was normalized to its highest expression level
over the time course. (C) mRNA expression of spt, ntl and four
targets at midgastrula (75% epiboly, 8 hpf) and early segmentation (11-13
hpf). These patterns have been previously reported: ntl
(Schulte-Merker et al., 1992 ),
spt (Griffin et al.,
1998 ), tbx6 (Hug et
al., 1997 ), dld
(Haddon et al., 1998 ;
Hans and Campos-Ortega, 2002 ),
cdx4 (Joly et al.,
1992 ) and msgn1 (Yoo
et al., 2003 ).
|
|

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 2. Spt and Ntl bind similar sites in vitro. (A,B)
Representative gel shifts using recombinant Spt-GST (A) and Ntl-GST (B).
(C,D) WebLogo (Crooks et
al., 2004 ) binding site models based on the sequences of >70
bound oligos from the in vitro selection assays are shown for Spt-GST (C) and
Ntl-GST (D) with the count matrices for the sequenced binding sites below.
Regions of binding sites contained in the non-random primer region of the
oligonucleotide were not counted, therefore some columns have fewer total
counts.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4. Spt binds clusters of T-box sites near tbx6 and deltaD
in vivo. We used qPCR to measure the enrichment of the genomic sequences
highlighted in blue in B-E in DNA precipitated using a Spt antibody.
(A,B) Regions of the T-box motif cluster upstream of
tbx6 (B) are 7.9±1.8 and 6.2±0.39-fold enriched in
Spt-bound DNA (A). A region of the intronic T-box motif cluster in the
dld second intron (C) is enriched 4.3±0.95 fold in
Spt-bound DNA (A). As a negative control, we determined the enrichment level
of parts of the rhodopsin (rho) (D) and v-maf
musculoaponeurotic fibrossarcoma oncogne protein b (mafba)
(E) upstream regions in Spt-bound DNA using qPCR and saw no enrichment
in Spt-bound DNA (A).
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5. T-box proteins bind putative regulatory sequences in vitro in a T-box
binding site-dependent manner. (A-F) To test whether Spt and Ntl
bind putative regulatory sequences in vitro, we performed gel shifts using
equal volumes of recombinant Spt-GST and Ntl-GST, and radiolabeled DNA
corresponding to putative tbx6 and dld genomic regulatory
sequences (shown as blue boxes in A and D and magnified in B and E to indicate
Spt/Ntl binding motifs a-d and a-g, respectively, as grey rectangles). Spt and
Ntl bind a 336 bp region containing four T-box sites just upstream of
tbx6 (C; lane 1 versus lane 2). Addition of 10-250x excess
unlabeled competitor competes well for binding and virtually eliminates
DNA-protein complex formation (C; lanes 3-5); however, excess unlabeled
competitor containing mutated T-box sites competes poorly (C; lanes 6-8).
Similarly, a mixture of equal volumes of Spt-GST and Ntl-GST binds a 475 bp
fragment from the dld second intron containing seven putative T-box
sites (F, lane 1 versus 2). Unlabeled competitor containing four of the T-box
sites competes for binding (F; lanes 3-5), but fails to compete when three of
the T-box sites are mutated (F, lanes 6-8).
|
|

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 6. The tbx6 regulatory element drives mesodermal gene expression
and requires Spt and Ntl for activity. The 1.7 kb region upstream of
tbx6 is shown with gray rectangles representing predicted Spt- and/or
Ntl-binding site motifs (A). This region drives reporter expression at
the margin at mid-gastrulation (B), but not if embryos are co-injected
with spt and ntl MOs (C) (mCherry, red; GFP, green).
(D-G) Endogenous tbx6 expression is decreased in spt-
(F) or ntl-depleted (E) embryos when compared with expression in
wild-type embryos (D). tbx6 expression is undetectable when both
ntl and spt are depleted (G).
|
|

View larger version (68K):
[in this window]
[in a new window]
|
Fig. 7. T-box sites are required for activity of the tbx6 mesodermal
regulatory region. (A) The 1.7kb region upstream of tbx6
is shown with gray rectangles representing predicted Spt- and/or Ntl-binding
site motifs. (B) A detailed view of 300 bp upstream of the
tbx6 transcription start site [gray rectangles indicate putative
T-box sites (a-d) and diamonds indicate Tcf/Lef-binding sites important for
regulatory element function (Szeto and
Kimelman, 2004 )]. (C,D) mCherry expression driven by
the full-length construct is robust at mid-gastrulation (8 hpf) (C) and
mid-segmentation (14 somites) (D). (E-P) During gastrulation, mCherry
expression driven by constructs in which one T-box site has been mutated
(E,H,K,N) is reduced (F,I,L,O), but is normal during segmentation (G,J,M,P).
(Q-S) When all four sites are mutated (Q) expression is abolished at
both stages (R,S). The percentages of embryos with robust, faint or no mCherry
expression are given in Table
1.
|
|

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 8. The second intron of deltaD contains a conserved cluster of
T-box sites required for T-box-dependent mesodermal expression. (A)
The second intron from fish dld orthologs (there is an unsequenced
gap in the Medaka intron). Grey rectangles represent T-box binding motifs,
diamonds indicate putative Tcf/Lef sites and grey ovals represent putative
Suppressor of Hairless-binding sites. (B) An alignment of the second
intron of fish dld orthologs reveals two particularly well-conserved
Spt/Ntl-binding motifs (sites c and d). (C-F) A construct containing
1.2 kb upstream and 1.3 kb downstream sequences relative to the dld
transcription start site, including the known neural regulatory element (HII)
(Hans and Campos-Ortega, 2002 )
and the T-box site cluster (C,D) drives robust mCherry expression in the
non-axial margin during gastrulation (E) and in the tail bud and somites
during segmentation (F). (G-I) When two well-conserved T-box sites
(c,d) and a T-box consensus sequence (e) are mutated (G), mCherry expression
is greatly reduced (H,I). The percentages of embryos with robust, faint or no
mCherry expression is given in Table
1.
|
|

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 9. The mesodermal deltaD regulatory element requires spt
and ntl function. (A-I) Stable transgenics carrying the
dld reporter construct (A) express mCherry at the blastoderm margin
during mid-gastrulation (G), and in the tail bud and hindbrain (C,D,H,I).
Transgene expression begins by 30% epiboly (E,F; animal pole views).
(J-M) Stable dld transgenics were injected with MOs targeting
ntl, spt or both transcripts, and analyzed by whole-mount in situ
hybridization for mCherry. Most uninjected control (J) and Ntl-depleted
embryos (K) expressed mCherry [76% (38/50) and 72% (26/36), respectively].
Only 67% (22/33) of Spt-depleted embryos expressed mCherry, and only 9% (3/33)
did so at a level comparable with that of uninjected controls (L). No
spt+ntl MO-injected embryos (0/54) expressed mCherry (M).
(N-Q) In situ hybridization revealed that endogenous dld
responds to Spt and Ntl depletion in a similar manner to the transgene.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
© The Company of Biologists Ltd 2009